Sienna Biopharmaceuticals, Inc. Stock Other OTC
Equities
SNNAQ
US82622H1086
Biotechnology & Medical Research
Financials (USD)
Sales 2017 | - | Sales 2018 | - | Capitalization | 48.12M |
---|---|---|---|---|---|
Net income 2017 | -50M | Net income 2018 | -73M | EV / Sales 2017 | - |
Net cash position 2017 | 74.47M | Net cash position 2018 | 18.4M | EV / Sales 2018 | - |
P/E ratio 2017 |
-3.5
x | P/E ratio 2018 |
-0.65
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 99.54% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 10-06-26 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 15-12-31 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 16-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 16-09-30 |
Founder | 59 | 10-06-26 |
1st Jan change | Capi. | |
---|---|---|
-3.17% | 102B | |
+1.72% | 96.07B | |
-1.80% | 21.66B | |
-17.50% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.21% | 13.79B | |
-0.10% | 13.33B | |
+20.79% | 10.94B |